AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Verran, DJ Gurkan, A Dilworth, P Painter, AD Dorney, CS Shun, A Koorey, D McCaughan, G Sheil, AGR
Citation: Dj. Verran et al., Inferior liver allograft survival from cadaveric donors > 50 years of age?, CLIN TRANSP, 15(2), 2001, pp. 106-110

Authors: Scott, RJ Meldrum, C Crooks, R Spigelman, AD Kirk, J Tucker, K Koorey, D
Citation: Rj. Scott et al., Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity, GUT, 48(4), 2001, pp. 508-514

Authors: Verran, DJ Gurkan, A Chui, AK Dilworth, P Koorey, D McCaughan, G Sheil, AGR
Citation: Dj. Verran et al., Pancreatitis in adult orthotopic liver allograft recipients: Risk factors and outcome, LIVER TRANS, 6(3), 2000, pp. 362-366

Authors: Chui, AKK Shi, LW Rao, ARN Verran, DJ Painter, D Koorey, D McCaughan, GW Sheil, AGR
Citation: Akk. Chui et al., Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: A revisit, TRANSPLAN P, 32(7), 2000, pp. 2101-2102

Authors: Rao, ARN Chui, AKK Gurkhan, A Shi, LW Al-Harbi, I Waugh, R Verran, DJ McCaughan, GW Koorey, D Sheil, AGR
Citation: Arn. Rao et al., Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: A singe-center experience, TRANSPLAN P, 32(7), 2000, pp. 2206-2207

Authors: Koorey, D Basha, NJ Tomaras, C Freiman, J Robson, L Smith, A
Citation: D. Koorey et al., Appendiceal carcinoma complicating adenomatous polyposis in a young woman with a de novo constitutional reciprocal translocation t(5;8)(q22;p23.1), J MED GENET, 37(1), 2000, pp. 71-75

Authors: Chui, AKK Rao, ARN Waugh, RC Mayr, M Verran, DJ Koorey, D McCaughan, GW Ong, J Sheil, AGR
Citation: Akk. Chui et al., Liver transplantation in patients with transjugular intrahepatic portosystemic shunts, AUST NZ J S, 70(7), 2000, pp. 493-495

Authors: McCaughan, GW Spencer, J Koorey, D Bowden, S Bartholomeusz, A Littlejohn, M Verran, D Chui, AKK Sheil, AGR Jones, RM Locarnini, SA Angus, PW
Citation: Gw. Mccaughan et al., Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis withvery low dose hepatitis B immune globulin, LIVER TR S, 5(6), 1999, pp. 512-519

Authors: Chui, AKK Rao, ARN McCaughan, GW Waugh, R Verran, DJ Koorey, D Painter, D Sheil, AGR
Citation: Akk. Chui et al., An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?, CLIN TRANSP, 13(6), 1999, pp. 531-535

Authors: Chui, AKK Rao, ARN McCaughan, GW Waugh, R Verran, DJ Koorey, D Sheil, AGR
Citation: Akk. Chui et al., Liver transplantation for hepatocellular carcinoma in cirrhotic patients, AUST NZ J S, 69(11), 1999, pp. 798-801
Risultati: 1-10 |